Remove Pharmaceuticals Remove Regulations Remove Webinar
article thumbnail

Best-in-Class Solutions Accelerate Development of GLP-1 Therapeutics

PPD

Medical researchers and practitioners see in their own patients how these ailments interconnect and overlap, as do the pharmaceutical and biotech companies working to develop GLP-1 therapeutics. Whatever the reason behind a patients fatigue, education and encouragement are key to continued engagement.

article thumbnail

Merck to buy Verona and its lung drug in $10B deal

BioPharma Drive: Drug Pricing

Tsai said he doesn’t expect any risks to the deal from antitrust regulators at the Federal Trade Commission. But the steady expansion of their use has slowed and, despite much trying, pharmaceutical companies have largely failed to top the drugs’ successes. Merck and Verona expect their transaction to close in the fourth quarter.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

What’s Next for Retail Pharmacy: Data, Debate, and Disruption (NEW Live Video Webinar)

Drug Channels

Fein, president of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for DCIs new live video webinar: Whats Next for Retail Pharmacy: Data, Debate, and Disruption This event will be broadcast live on: Friday, June 20, 2025 12:00 p.m. It is part of The Drug Channels 2025 Video Webinar Series.

article thumbnail

How To Enter The Japanese Market - Navigating Regulations & Quality Standards

Fierce BioTech

Join us for an exclusive webinar where well guide you through the essential steps of meeting Japans regulations and strict quality requirement. Join us for an exclusive webinar where well guide you through the essential steps of meeting Japans regulations and strict quality requirement.

article thumbnail

The rise of GLP-1 drugs: Transforming weight loss treatment

BioPharma Drive: Drug Pricing

Understanding GLP-1 drugs GLP-1, or glucagon-like peptide-1 receptor modulators, mimic natural hormones that regulate insulin and appetite. Originally developed in the 1970s to treat diabetes, these drugs—such as Ozempic, Wegovy, and Mounjaro—have become headline-makers for their ability to induce significant weight loss.

Treatment 130
article thumbnail

Article EMA Thank You What we expect European regulators to do in May 2024

Agency IQ

What we expect European regulators to do in May 2024 In this recurring feature, AgencyIQ, through public data and previous analysis, determines what European medicine and device regulators will likely do in the month ahead, including key deadlines, meetings, events, planned regulations, comment periods, and more.

article thumbnail

Article EMA Thank You British regulators tease new device regulations in informative live session

Agency IQ

British regulators tease new device regulations in informative live session This week, the British regulator MHRA offered a new peek into its planned medical device regulations. BY COREY JASEPH, MS, RAC | MAR 5, 2024 11:10 PM CST Quick background on medical device regulation in the U.K. post-market regulation here.]